Patents
Literature
Hiro is an intelligent assistant for R&D personnel, combined with Patent DNA, to facilitate innovative research.
Hiro

215 results about "Disease" patented technology

A disease is a particular abnormal condition that negatively affects the structure or function of part or all of an organism, and that is not due to any external injury. Diseases are often construed as medical conditions that are associated with specific symptoms and signs. A disease may be caused by external factors such as pathogens or by internal dysfunctions. For example, internal dysfunctions of the immune system can produce a variety of different diseases, including various forms of immunodeficiency, hypersensitivity, allergies and autoimmune disorders.

Non-mammalian GnRH analogs and uses thereof in the immune system

InactiveUS20050043245A1Effective supervisionHigh affinityPeptide/protein ingredientsLuteinising hormone-releasing hormoneDiseaseD-Arginine
Specially designed non-mammalian GnRH, its analogs, or biometics resistant to degradation by peptidase, are disclosed. The GnRH analogs are further defined as analogs of GnRH II or salmon GnRH. These non-mammalian analogs incorporate D-arginine, D-leucine, D-tBu-Serine, D-Trp or other active D amino acids at position 6 and ethylamide, aza-Gly-amide or other Gly amide at position 10. The D-Arg (6)—GnRH II-ethylamide, D-Arg (6)—GnRH II-aza-Gly (10)-amide, the D-Arg (6)—salmon GnRH ethylamide, and D-Arg (6)—salmon GnRH-aza-Gly (10)-amide analogs are also provided, and demonstrate preferential binding to immune system non-mammalian GnRH receptors. These non-mammalian GnRH or its analogs, or long-acting preparation, biometics or their antibodies may be used in pharmaceutical preparation, and specifically in treatment of various immune system disorders. The non-mammalian GnRH or its analogs are also provided in pharmaceutical preparations that may be used clinically for treating immune system disorders when used in very low doses and administered in pulsatile fashion. The aza-Gly (10) amide non-mammalian analogs are yet other embodiments of the non-mammalian GnRH or its analogs provided as a part of the invention. The use of agents that regulate the production or antibodies or In addition, the detection of non-mammalian GnRH or GnRH II or the non-mammalian GnRH receptors may be used as a diagnostic tool.
Owner:SILER KHODR THERESA

Materials and methods for treating neuropathies and related disorders including those involving a keystone nerve

InactiveUS20160030408A1Increase blood flowAlter perception of painBiocideElectrotherapyDiseaseMedicine
Methods, apparatus, compositions and kits for inhibiting a disorder in a human patient, including non-cerebral neurovascular disorder or muscular headache pain, or loss of motor or sensory function, sympathetic tone or range or fluidity of motion that affect a nerve pathway at more than one locus associated with the disorder to inhibit the disorder. Alternatively or in addition, neuropathy associated with a disorder is treatable by palpating to determine a Keystone nerve essential to the neuropathy, applying pressure to determine a point of maximum discomfort or trigger of increased symptoms to identify a Levin Sign as a locus of initial intervention, and intervening to treat the neuropathy at the location of the Levin Sign by administering a pharmaceutically active agent, internal implanted or external neuro stimulation affecting the nerve pathway to inhibit the neuropathy.
Owner:BHL PATENT HLDG

Method for ecologically cultivating freshwater shrimps in paddy

ActiveCN103931529AAvoid pollutionAvoid influenceClimate change adaptationPisciculture and aquariaDiseaseFresh water organism
The invention discloses a method for ecologically cultivating freshwater shrimps in a paddy. The method includes the following steps that the paddy is fertilized and then raked, a communicated cultivating ditch is excavated in the raked paddy, a field ridge is built around the cultivating ditch with excavated soil, the height of the field ridge ranges from 45 cm to 70 cm, and the width of the field ridge ranges from 60 cm to 90 cm; the cultivating ditch is provided with a water inlet and a drainage opening, the water inlet and the drainage opening are respectively provided with a device preventing the freshwater shrimps from escaping, a pond occupying 5%-8% of the area of the whole paddy is excavated on the water inlet, and the depth of the pond ranges from 80 cm to 110 cm; the paddy is sterilized through calcium oxide; seedlings of a rice variety are inserted into the sterilized paddy, wherein the stalks of the seedlings are thick and strong, the seedlings are resistant to lodging, diseases and fertility and grow in deep water, and the yield is high; the freshwater shrimps are fed after the seedlings turn green; bait is thrown during cultivating according to the freshwater shrimps in different growth stages, and meanwhile water keeps clean. The freshwater shrimps cultivated in the method are natural and free of pollution and are pure green food.
Owner:JIAXING VOCATIONAL TECHN COLLEGE

Methods for the treatment of lada and other adult- onset autoimmune using immunosuppressive monoclonal antibodies with reduced toxicity

InactiveUS20100015142A1Low toxicityDamage autoimmunityMetabolism disorderAntibody ingredientsDiseaseAutoimmune responses
The present invention provides methods of treating, preventing or ameliorating the symptoms of Latent Autoimmune Diabetes in Adults (LADA) and adult-onset type 1 diabetes through the use of anti-human CD3 antibodies. In particular, in invention provides methods of preventing or delaying insulin requirement in patients diagnosed with LADA. The methods of the invention provide for administration of antibodies that specifically bind the epsilon subunit within the human CD3 complex. Such antibodies modulate the T cell receptor / alloantigen interaction and, thus, regulate the T cell mediated cytotoxicity associated with autoimmune disorders. Additionally, the invention provides for modification of the anti-human CD3 antibodies such that they exhibit reduced or eliminated effector function and T cell activation as compared to non-modified anti-human CD3 antibodies.
Owner:MACROGENICS INC

Amorphous and a crystalline form of genz 112638 hemitartrate as inhibitor of glucosylceramide synthase

ActiveUS20130137743A1BiocideMetabolism disorderDiseaseCrystallography
The hemitartrate salt of a compound represented by the following structural formula: (Formula I Hemitartrate), which may be used in pharmaceutical applications, are disclosed. Particular single crystalline forms of the Formula (I) Hemitartrate are characterized by a variety of properties and physical measurements. As well, methods of producing crystalline Formula (I) Hemitartrate, and using it to inhibit glucosylceramide synthase or lowering glycosphingolipid concentrations in subjects to treat a number of diseases, are also discussed. Pharmaceutical compositions are also described.
Owner:GENZYME CORP

Anti-stress synbiotics traditional Chinese medicine composition applicable to chicken and preparation method of anti-stress synbiotics traditional Chinese medicine composition

InactiveCN103168965AAnticonvulsantHas a cooling effectInanimate material medical ingredientsAnimal feeding stuffDiseaseAnti stress
The invention relates to the field of livestock breeding and particularly relates to an anti-stress synbiotics traditional Chinese medicine composition for chicken. The anti-stress synbiotics traditional Chinese medicine composition consists of a micro-ecological synbiotics feed additive and a Chinese herbal medicine additive, wherein the micro-ecological synbiotics feed additive consists of the following components in parts by weight: 10-60 parts of micro-ecological probiotics and 40-90 parts of oligosaccharide, 20-45 billion living bifidobacteria are contained in per gram of micro-ecological synbiotics feed additive, the micro-ecological probiotics are a bifidobacteria preparation, the oligosaccharide is any one or more of fructooligosaccharide, xylooligosaccharide, isomaltooligosacharide and soybean oligosaccharides, the micro-ecological synbiotics feed additive accounts for 1-2% of the total weight of the anti-stress synbiotics traditional Chinese medicine composition for chicken, and the Chinese herbal medicine additive consists of the following components in parts by weight: 3-5 parts of schisandra, 10-15 parts of keels, 15-18 parts of zizyphus jujube kernel, 10-20 parts of nymphaea tetragona and 25-30 parts of clover. The anti-stress synbiotics traditional Chinese medicine composition can be used for improving the immunity and anti-stress capability of the chicken, and reducing the incidence of diseases.
Owner:CHONGQING ACAD OF ANIMAL SCI +1

Double-layer dragon fruit planting method

ActiveCN107258270AMeet the growth characteristicsIncrease productionExcrement fertilisersBioloigcal waste fertilisersDiseaseLand resources
The invention discloses a double-layer dragon fruit planting method. Rectangular pieces are made firstly, the line spacing is 2.8-3.2 m, the width of the rectangular pieces is 1.4-1.8 m, and the height of the rectangular pieces is 20-30 cm. Cement columns with the radius of 5-7 cm are uniformly arranged on the rectangular pieces at intervals of 2-3 m, wherein the height is 175-185 cm. Two layers of rectangular frames are arranged on the columns, the lower-layer height is 95-105 cm, the upper-layer height is 170-180 cm, and the upper layer of rectangular frames is 3-5 cm away from the top ends of the columns. The width of the rectangular frames is 26-35 cm. Bamboo poles are arranged among the columns, long and short bamboo poles are arranged at intervals, long bamboo poles are connected with upper-layer long rods, short bamboo poles are connected with lower-layer long rods, and the separation distance of the bamboo poles is 40-50 cm. During planting, seedling selection, leveling, fertilization and separated planting, water and fertilizer management, branch pruning, flower and fruit management and dragon fruit planting management of disease and pest prevention and control are performed. The double-layer dragon fruit planting method adopts planting frames on the premise that the dragon fruit growth requirement is met and fully utilizes land resources and light conditions, the acre yield, quality and sweetness of dragon fruits are improved, and the economic benefits of dragon fruit planting are increased.
Owner:罗明艺

Identification method for clubroot resistance of alpine radish at seedling stage

InactiveCN106520908AStrong disease resistanceIncrease resistanceMicrobiological testing/measurementDiseaseTheoretical research
The invention discloses an identification method for the clubroot resistance of alpine radish at the seedling stage. The identification method is characterized by comprising the following steps: S1, sieving soil of cultivated land, adding with a fertilizer and plant ash, mixing sterile soil with an organic fertilizer and calcium superphosphate, in addition, adding with plant ash, and preparing culture soil; S2, taking a hole tray as a culture device, adding the culture soil obtained in S1 into the hole tray, and sowing the seeds with the variety to be identified in the hole tray; S3, grinding fungus roots containing plasmodiophoromycetes, filtering the grinded fungus roots by adopting gauze, preparing a pathogenic spore solution, carrying out counting by adopting a blood counting chamber, preparing the spore solution into inoculating bacteria liquid with the concentration being 1x10<7> spores/ml for later use; S4, adding the culture soil into the hole tray for later use; and S5, completely watering the culture soil in the hole tray, when the water settles and the soil is slightly dry and is suitable for sowing, carrying out dibble seeding and earthing at the central point of each hole, establishing a small shed, carrying out normal field management, and investigating the morbidity at the 7th week after inoculation. According to the identification method provided by the invention, through the root irrigation identification method, the clubroot resistance of relevant experimental population can be improved, and thus the method has great values for the disease-resisting breeding practice and theoretical research.
Owner:INST OF ECONOMIC CROP HUBEI ACADEMY OF AGRI SCI

Traditional Chinese medicine for treating acute pharyngitis

InactiveCN101167947ACompatibility is simpleLow costAnthropod material medical ingredientsRespiratory disorderPeriostracumDisease
A Chinese traditional medicament for curing acute pharyngitis belongs to a Chinese traditional medicament for curing acute and chronic pharyngitis, comprising rehmanniae radix 20g, liriope and scutellaria separately 15g, figwort 12g, balloonflower 10g, liquorice 6g, oroxylum indicum 10g, honeysuckle 15g, and mint 6g; wherein the assistant medicaments are that the person having throat itching can charge periostracum cicadae 10g, the person having heavy cough can charge fritillaria 10g, and the person whose follicle is scarlet and assumes the clustered pattern can charge weeping forsythia and blackberry lily separately 10g. The invention uses natural Chinese herbal medicaments as the dispensing materials in the prescription and then is made by employing traditional processing method, the materials are easy to obtain, the prescription and the process for preparation are simple, and the charge of manufacturing medicament is low. The Chinese herbal composition is simple, the medicaments used in the medicament prescription are completely natural herbal medicaments, and the obtaining and the utilizing are convenient. The process for preparation is simple, the curing effect after taking the invention is good, and the price of the medicament is low. Especially the invention can be applicable to people reside in remote villages far away from towns. The curing charge is low towards people having acute pharyngitis. The invention solves the problems that the household income is low, the life is poor, and the medical treatment condition for curing in local is lacked.
Owner:吴月

In vitro detection kit for TAFI content

The invention discloses an in vitro detection kit for thrombin-activatable fibrinolysis inhibitor (TAFI) content. The kit is used for the in vitro detection of the TAFI content by using the biological property that a polyamidoamine (PAMAM) dendritic polymer can be combined with an antibody and combining the traditional enzyme-linked immuno sorbent assay (ELISA) method, and the kit develops a new in vitro diagnostics method for the TAFI and improves the sensitivity of the TAFI in vitro detection. The kit comprises an antibody coated ELISA plate, a sample diluent, a TAFI standard, a detergent, a PAMAM-labeled horse radish peroxidase-linked antibody, an antibody diluent, color development buffer solution, 30 percent hydrogen peroxide, o-phenylenediamine and stop solution. The kit overcomes the defects of expensive equipment, long detection time and the like in the prior art; compared with other detection kits, the kit is simple, convenient and fast in operation, low in cost, sensitive in diagnosis and has low detection limit and the like; the kit for auxiliary diagnosis improves the detection rate and the accuracy of related diseases, and fulfills the purposes of early discovery and early treatment; and the kit reduces unnecessary pain and medicinal expense of examined persons, and improves the quality of life of the examined persons.
Owner:LIAONING MEDI BIOTECH CO LTD

Chinese patent medicine for treating idiopathic edema

InactiveCN102366617AEdema disappearsReduce puffinessBlood disorderPlant ingredientsDiseaseSide effect
The invention provides a Chinese patent medicine for treating idiopathic edema, which comprises the following components by weight part: 9-15 parts of tribulus terrestris, 8-12 parts of semen psoraleae, 6-10 parts of radix angelicae, 4-8 parts of placenta hominis, 4-8 parts of fleece flower root, 3-5 parts of Maytenus hookeri, 1-3 parts of gen-seng and 1-3 parts of spatholobus stem. Compared with the prior art, the Chinese patent medicine of the present invention aims at internal disease of idiopathic edema, is capable of performing therapies with syndrome differentiation, and has the advantages of fast curative effect, low cost, no toxicity, no side-effect and substantial effect. The Chinese patent medicine for treating idiopathic edema treats both principal and secondary aspect of disease.
Owner:CHENGDU LYUDI TECH

Compound Chinese mugwort essential oil

InactiveCN103007104AAnti agingSafe and effectiveAntinoxious agentsImmunological disordersDiseaseMugwort Essential Oil
The invention belongs to health care products, and in particular relates to compound Chinese mugwort essential oil which is formed by comprising the following steps of: uniformly mixing sweet almond oil, wheatgerm oil, grape seed oil, Chinese mugwort essential oil, cinnamon essential oil, syzygium aromaticum essential oil, angelica essential oil and chamomile essential oil uniformly, subpackaging and sealing. The compound Chinese mugwort essential oil provided by the invention adopts pure natural plant ingredients, scientifically mixes and coordinates multiple kinds of plant essential oil, plays effects through permeation and absorption of skin, main and collateral channels and acupuncture points, has obvious and safe curative effects, has no side effect, can be used for a long time, is fragrant and pleasant in flavor, has the effects of discharging the toxin, boosting the immunity, improving the organism resistance, preventing diseases, keeping fit, and delaying the organism senescence.
Owner:AESTHETIC TECH BEIJING +1

Traditional Chinese medicine microbial ecological agent for preventing and treating infectious bursal disease of chicken and preparation method thereof

InactiveCN103961418AIncrease the number ofImprove disease resistanceAntiviralsPlant ingredientsBiotechnologyDisease
The invention provides a traditional Chinese medicine microbial ecological agent for preventing and treating infectious bursal disease of chicken and a preparation method thereof. The preparation method comprises the following steps: adding water to radix isatidis, honeysuckle, forsythia, folium isatidis, humulus scandens, radix scutellariae, dangshen, ageratum, plantain, astragalus membranaceus, angelica sinensis and liquorice, boiling by using high heat, preserving heat for 30-60 minutes by using slow fire, cooling, filtering, collecting filtrate, adding white sugar, boiling, cooling to a normal temperature, then inoculating lactobacillus, zygosaccharomyces bailii and acetobacter xylinum, and fermenting for 3-7 days so as to obtain the microbial ecological agent. After the microbial ecological agent is diluted proportionally, the diluted microbial ecological agent is directly drunk by chicken. The traditional Chinese medicine microbial ecological agent provided by the invention has the effects of resisting viruses, inducing interferon, increasing the quantity of effective microbial communities in intestinal tracts, boosting immunity and improving disease resistance of chickens without toxic or side effects and the like; the preparation method is simple, convenient to use and high in viable bacteria content and has no residues. The traditional Chinese medicine microbial ecological agent provided by the invention has a certain curative effect on infectious bronchitis and henpox and relatively good market prospect.
Owner:广州中冠动物药业有限公司
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products